UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atopic dermatitis: the skin barrier and beyond

British journal of dermatology (1951), 2019-03, Vol.180 (3), p.464-474

2019

Volltextzugriff (PDF)

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1158-1166

2020

Volltextzugriff (PDF)

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009

British journal of dermatology (1951), 2009-11, Vol.161 (5), p.987-1019

2009

Volltextzugriff (PDF)

The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives

British journal of dermatology (1951), 2012-03, Vol.166 (3), p.545-554

2012

Volltextzugriff (PDF)

Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

British journal of dermatology (1951), 2020-08, Vol.183 (2), p.404-406

2020

Volltextzugriff (PDF)

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

British journal of dermatology (1951), 2018-05, Vol.178 (5), p.1083-1101

2018

Volltextzugriff (PDF)

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study

British journal of dermatology (1951), 2006-07, Vol.155 (1), p.160-169

2006

Volltextzugriff (PDF)

Response to: ‘Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)’: reply from the authors

British journal of dermatology (1951), 2022-05, Vol.186 (5), p.909-910

2022

Volltextzugriff (PDF)

The development of sarcoidosis on antitumour necrosis factor therapy: a paradox

British journal of dermatology (1951), 2010-09, Vol.163 (3), p.648-649

2010

Volltextzugriff (PDF)

Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

British journal of dermatology (1951), 2020-08, Vol.183 (2), p.294-302

2020

Volltextzugriff (PDF)

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update

British journal of dermatology (1951), 2020-10, Vol.183 (4), p.628-637

2020

Volltextzugriff (PDF)

Risk of cancer in patients with psoriasis on biological therapies: a systematic review

British journal of dermatology (1951), 2018-01, Vol.178 (1), p.103-113

2018

Volltextzugriff (PDF)

Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.946-953

2019

Volltextzugriff (PDF)

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

British journal of dermatology (1951), 2017-09, Vol.177 (3), p.628-636

2017

Volltextzugriff (PDF)

Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.1068-1070

2019

Volltextzugriff (PDF)

Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single‐centre, prospective 1‐year observational cohort study of the first 100 patients treated

British journal of dermatology (1951), 2021-04, Vol.184 (4), p.755-757

2021

Volltextzugriff (PDF)

Screening for anxiety and depression in people with psoriasis: a cross‐sectional study in a tertiary referral setting

British journal of dermatology (1951), 2017-04, Vol.176 (4), p.1028-1034

2017

Volltextzugriff (PDF)

通过注射氨甲喋呤治疗银屑病

British journal of dermatology (1951), 2018-07, Vol.179 (1), p.e87-e87

2018

Volltextzugriff (PDF)

Methotrexate injections for psoriasis

British journal of dermatology (1951), 2018-07, Vol.179 (1), p.e73-e73

2018

Volltextzugriff (PDF)

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

British journal of dermatology (1951), 2016-06, Vol.174 (6), p.1194-1227

2016

Volltextzugriff (PDF)

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis

British journal of dermatology (1951), 2020-10, Vol.183 (4), p.638-649

2020

Volltextzugriff (PDF)

Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses

British journal of dermatology (1951), 2013-05, Vol.168 (5), p.954-967

2013

Volltextzugriff (PDF)

银屑病和银屑病关节炎中的体重减轻

British journal of dermatology (1951), 2019-11, Vol.181 (5)

2019

Volltextzugriff (PDF)

British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

British journal of dermatology (1951), 2016-07, Vol.175 (1), p.23-44

2016

Volltextzugriff (PDF)

Exposure to biological therapies during conception and pregnancy: a systematic review

British journal of dermatology (1951), 2018-01, Vol.178 (1), p.95-102

2018

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(150)

Publikationsform

Artikel
(149)
Berichte
(4)

Sprache

Englisch
(153)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(94)
Dermatology
(75)
Humans
(75)
Psoriasis
(48)
Biological And Medical Sciences
(44)
Male
(44)
Medical Sciences
(38)
Female
(37)
Psoriasis - Drug Therapy
(37)
Adult
(33)
Middle Aged
(30)
Psoriasis. Parapsoriasis. Lichen
(23)
Treatment Outcome
(23)
Aged
(18)
Monoclonal Antibodies
(16)
Dermatologic Agents - Therapeutic Use
(13)
Risk Factors
(13)
Dermatologic Agents - Adverse Effects
(12)
Etanercept
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford journals
(153)
Ovid Journals
(143)
Wiley Online Library All Journals
(125)
Wiley Online Library
(120)
MEDLINE
(83)
EZB Electronic Journals Library
(30)
Oxford Journals 2020 Medicine
(20)
Ingenta
(14)
JSTOR
(6)
Publisher or Other Site
(6)
IngentaConnect Journals
(2)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1)

7 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Atopic dermatitis: the skin barrier and beyond

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009

The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives

Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study

Response to: ‘Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)’: reply from the authors

The development of sarcoidosis on antitumour necrosis factor therapy: a paradox

Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update

Risk of cancer in patients with psoriasis on biological therapies: a systematic review

Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series

Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single‐centre, prospective 1‐year observational cohort study of the first 100 patients treated

Screening for anxiety and depression in people with psoriasis: a cross‐sectional study in a tertiary referral setting

通过注射氨甲喋呤治疗银屑病

Methotrexate injections for psoriasis

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis

Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses

银屑病和银屑病关节炎中的体重减轻

British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

Exposure to biological therapies during conception and pregnancy: a systematic review

Aktive Filter

Suchergebnisse filtern